Hear more about IPC's Psoriasis Severity Classification from IPC experts
*Easier to access, no login required
Learn more
Latest News from the IPC
Video Series on IPC’s Psoriasis Severity ReclassificationMarch 30, 2021 Janssen Phase-3 TREMFYA® Clinical TrialMarch 29, 2021 Sun Pharma Phase-3 ILUMYA® Clinical TrialMarch 28, 2021 Update on PsoProtect Registry DataMarch 17, 2021
IPC is dedicated to providing the latest medical and scientific information on coronavirus and its impact on psoriasis
IPC STATEMENT on SARS-CoV-2 Vaccines and Psoriasis Six key take-aways that physicians and other healthcare practitioners should consider when administering the SARS-CoV-2 vaccine to psoriasis patients. READ FULL STATEMENT
Six key take-aways that physicians and other healthcare practitioners should consider when administering the SARS-CoV-2 vaccine to psoriasis patients.
READ FULL STATEMENT
Upcoming Virtual Symposia MAY 7 SID Biomarkers in psoriasis and psoriatic arthritis: Moving towards personalized therapy View Agenda July 3 IFPA The International Psoriasis Council Update on the Latest Research AGENDA COMING SOON More Events
View Agenda
AGENDA COMING SOON